The New York Times has two stories on pharmaceutical industry payments to physicians and experts. In the first, the paper reports that the new federal health care law will require drug companies and medical device makers to disclose payments made to doctors, starting in 2013. Some of the big drug makers already have released their databases, though "many followers of the pharmaceutical industry are still finding it far too difficult to follow the money. ... The money disclosed in such databases can be substantial...
More...
More...